News & Articles

Find out how one lab is streamlining the development of lentiviruses and transduction enhancers to treat a range of genetic diseases

Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors

New partnership to advance Nosopharm’s lead candidate to clinical stage

Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology

Attend this free expert webinar to learn about the applications of spectroscopy in clinical research

Recommendation based on the results of IMpassion130 study in triple-negative breast cancer, an aggressive type of breast cancer with high unmet medical need

Avacta’s first Affimer clinical candidate is a potent PD-L1 antagonist under development for solid tumor indications as the basis of bispecific and combination therapies

A small team of biotech scientists is targeting patient specific ‘neoantigens’ to improve response to adoptive T cell therapy in acute myeloid leukemia (AML)

Project to focus on data-driven cell conversions to produce cell therapies with potential application in wound healing, and oncology immunotherapy

The drug works by targeting the protein responsible for the death of heart cells during an attack

Immunology-focused pharma company INmune Bio is set to start first-in-man clinical trials with a promising anti-TNF compound that could revolutionize the treatment of Alzheimer’s disease and related symptoms

Scientists at the University of Southern California have identified blood-based biomarker patterns that indicate early-stage disease

Sativex® for the Treatment of AgitatioN in Dementia (STAND trial)

Optical topography to reduce patient burden in the treatment of attention-deficit hyperactivity disorder

Discover how the use of high-throughput pipetting tools can facilitate this cutting-edge gene-editing tool

Surgical transfer of nerves enables a change in muscle identity to improve prosthesis connection and movement

Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission